Try Fund Library Premium
For Free with a 30 day trial!
Global Equity
Click for more information on Fundata’s FundGrade.
|
NAVPS (04-07-2026) |
$15.44 |
|---|---|
| Change | - |
As at February 28, 2026
Inception Return (June 21, 2021): 10.02%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | 7.72% | 6.77% | 8.52% | 10.15% | -1.85% | 4.85% | 14.78% | 10.31% | - | - | - | - | - | - |
| Benchmark | 2.25% | 3.44% | 11.12% | 4.38% | 18.33% | 20.04% | 20.72% | 14.77% | 13.20% | 14.90% | 13.52% | 11.99% | 12.31% | 13.10% |
| Category Average | 1.67% | 2.38% | 7.91% | 3.22% | 12.94% | 14.63% | 15.64% | 10.72% | 9.69% | 11.51% | 10.36% | 9.14% | 9.43% | 10.09% |
| Category Rank | 17 / 1,082 | 52 / 1,082 | 506 / 1,066 | 19 / 1,082 | 980 / 1,041 | 940 / 997 | 411 / 913 | 405 / 877 | - | - | - | - | - | - |
| Quartile Ranking | 1 | 1 | 2 | 1 | 4 | 4 | 2 | 2 | - | - | - | - | - | - |
| Return % | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | -4.62% | -5.85% | 0.53% | 0.68% | -1.42% | 0.95% | 1.16% | -3.15% | 3.74% | -3.07% | 2.26% | 7.72% |
| Benchmark | -4.18% | -2.97% | 5.37% | 3.64% | 2.87% | 1.95% | 4.75% | 2.78% | -0.21% | -0.91% | 2.09% | 2.25% |
10.94% (February 2024)
-7.33% (June 2022)
| Return % | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | - | - | - | - | - | - | 0.41% | 13.27% | 26.00% | -6.59% |
| Benchmark | 5.18% | 16.29% | -1.79% | 21.41% | 13.15% | 17.62% | -12.64% | 19.37% | 26.84% | 16.60% |
| Category Average | 3.86% | 14.23% | -5.38% | 19.94% | 11.73% | 16.21% | -13.86% | 15.08% | 20.13% | 12.89% |
| Quartile Ranking | - | - | - | - | - | - | 1 | 2 | 1 | 4 |
| Category Rank | - | - | - | - | - | - | 23/ 876 | 350/ 910 | 124/ 997 | 1,040/ 1,041 |
26.00% (2024)
-6.59% (2025)
Beneva GQG Partners Global Equity GIF
Median
Other - Global Equity
| Standard Deviation | 12.19% | - | - |
|---|---|---|---|
| Beta | 0.82% | - | - |
| Alpha | -0.01% | - | - |
| Rsquared | 0.37% | - | - |
| Sharpe | 0.89% | - | - |
| Sortino | 1.81% | - | - |
| Treynor | 0.13% | - | - |
| Tax Efficiency | 100.00% | - | - |
| Volatility |
|
- | - |
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | 13.15% | 12.19% | - | - |
| Beta | 0.65% | 0.82% | - | - |
| Alpha | -0.12% | -0.01% | - | - |
| Rsquared | 0.25% | 0.37% | - | - |
| Sharpe | -0.27% | 0.89% | - | - |
| Sortino | -0.44% | 1.81% | - | - |
| Treynor | -0.05% | 0.13% | - | - |
| Tax Efficiency | - | 100.00% | - | - |
| Start Date | June 21, 2021 |
|---|---|
| Instrument Type | Segregated Fund |
| Share Class | - |
| Legal Status | Trust |
| Sales Status | Open |
| Currency | CAD |
| Distribution Frequency | No Distribution |
| Assets ($mil) | $13 |
| FundServ Code | Load Code | Sales Status |
|---|---|---|
| BNVA0182 | ||
| BNVA1182 | ||
| BNVA2182 | ||
| BNVA3182 |
The fund is invested in units of the GQG Partners Global Equity fund, which objective is to outperform the benchmark index over the long term, while providing more attractive risk-adjusted returns than the benchmark index. The fund is mainly invested in the equities of large-cap global companies, mostly located outside of Canada.
-
| Portfolio Manager |
Multi-Managers |
|---|---|
| Sub-Advisor |
- |
| Fund Manager |
Multi-Managers |
|---|---|
| Custodian |
- |
| Registrar |
- |
| Distributor |
- |
| RSP Eligible | Yes |
|---|---|
| PAC Allowed | Yes |
| PAC Initial Investment | 40 |
| PAC Subsequent | - |
| SWP Allowed | Yes |
| SWP Min Balance | - |
| SWP Min Withdrawal | - |
| MER | 3.49% |
|---|---|
| Management Fee | 2.95% |
| Load | Choice of Front or No Load |
| FE Max | - |
| DSC Max | - |
| Trailer Fee Max (FE) | - |
| Trailer Fee Max (DSC) | - |
| Trailer Fee Max (NL) | - |
| Trailer Fee Max (LL) | - |
Try Fund Library Premium
For Free with a 30 day trial!